6-29942985-A-G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_002116.8(HLA-A):​c.302A>G​(p.Asp101Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as no classification for the single variant (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D101N) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.029 ( 102 hom., cov: 5)
Exomes 𝑓: 0.045 ( 3875 hom. )
Failed GnomAD Quality Control

Consequence

HLA-A
NM_002116.8 missense

Scores

16

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.47

Publications

20 publications found
Variant links:
Genes affected
HLA-A (HGNC:4931): (major histocompatibility complex, class I, A) HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen so that they can be recognized by cytotoxic T cells. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. More than 6000 HLA-A alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.[provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002359569).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0285 (1474/51706) while in subpopulation NFE AF = 0.0349 (934/26754). AF 95% confidence interval is 0.0331. There are 102 homozygotes in GnomAd4. There are 701 alleles in the male GnomAd4 subpopulation. Median coverage is 5. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 1474 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002116.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HLA-A
NM_002116.8
MANE Select
c.302A>Gp.Asp101Gly
missense
Exon 2 of 8NP_002107.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HLA-A
ENST00000376809.10
TSL:6 MANE Select
c.302A>Gp.Asp101Gly
missense
Exon 2 of 8ENSP00000366005.5P04439-1
HLA-A
ENST00000952344.1
c.302A>Gp.Asp101Gly
missense
Exon 2 of 8ENSP00000622403.1
HLA-A
ENST00000706894.1
c.302A>Gp.Asp101Gly
missense
Exon 3 of 8ENSP00000516610.1A0A9L9PYF9

Frequencies

GnomAD3 genomes
AF:
0.0285
AC:
1471
AN:
51686
Hom.:
102
Cov.:
5
show subpopulations
Gnomad AFR
AF:
0.0164
Gnomad AMI
AF:
0.0443
Gnomad AMR
AF:
0.0301
Gnomad ASJ
AF:
0.0369
Gnomad EAS
AF:
0.00624
Gnomad SAS
AF:
0.0284
Gnomad FIN
AF:
0.0252
Gnomad MID
AF:
0.0119
Gnomad NFE
AF:
0.0349
Gnomad OTH
AF:
0.0219
GnomAD2 exomes
AF:
0.0422
AC:
9524
AN:
225872
AF XY:
0.0432
show subpopulations
Gnomad AFR exome
AF:
0.0157
Gnomad AMR exome
AF:
0.0302
Gnomad ASJ exome
AF:
0.0493
Gnomad EAS exome
AF:
0.00511
Gnomad FIN exome
AF:
0.0467
Gnomad NFE exome
AF:
0.0539
Gnomad OTH exome
AF:
0.0490
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0452
AC:
45097
AN:
998028
Hom.:
3875
Cov.:
19
AF XY:
0.0457
AC XY:
22572
AN XY:
494100
show subpopulations
African (AFR)
AF:
0.0136
AC:
308
AN:
22700
American (AMR)
AF:
0.0323
AC:
797
AN:
24688
Ashkenazi Jewish (ASJ)
AF:
0.0457
AC:
716
AN:
15666
East Asian (EAS)
AF:
0.00381
AC:
53
AN:
13910
South Asian (SAS)
AF:
0.0387
AC:
2417
AN:
62434
European-Finnish (FIN)
AF:
0.0449
AC:
1623
AN:
36114
Middle Eastern (MID)
AF:
0.0578
AC:
186
AN:
3218
European-Non Finnish (NFE)
AF:
0.0479
AC:
37323
AN:
779950
Other (OTH)
AF:
0.0425
AC:
1674
AN:
39348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
907
1814
2722
3629
4536
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1402
2804
4206
5608
7010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0285
AC:
1474
AN:
51706
Hom.:
102
Cov.:
5
AF XY:
0.0277
AC XY:
701
AN XY:
25342
show subpopulations
African (AFR)
AF:
0.0166
AC:
181
AN:
10926
American (AMR)
AF:
0.0301
AC:
108
AN:
3586
Ashkenazi Jewish (ASJ)
AF:
0.0369
AC:
36
AN:
976
East Asian (EAS)
AF:
0.00626
AC:
11
AN:
1756
South Asian (SAS)
AF:
0.0286
AC:
44
AN:
1538
European-Finnish (FIN)
AF:
0.0252
AC:
127
AN:
5046
Middle Eastern (MID)
AF:
0.0125
AC:
1
AN:
80
European-Non Finnish (NFE)
AF:
0.0349
AC:
934
AN:
26754
Other (OTH)
AF:
0.0219
AC:
14
AN:
638
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.423
Heterozygous variant carriers
0
44
87
131
174
218
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0436
Hom.:
49
ExAC
AF:
0.0417
AC:
4828

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
5.0
DANN
Benign
0.48
DEOGEN2
Benign
0.039
T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.0081
N
LIST_S2
Benign
0.034
T
MetaRNN
Benign
0.0024
T
MetaSVM
Benign
-0.91
T
PhyloP100
-1.5
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-1.0
N
REVEL
Benign
0.091
Sift
Benign
0.068
T
Sift4G
Benign
0.17
T
Polyphen
0.058
B
Vest4
0.060
MPC
0.17
ClinPred
0.0074
T
GERP RS
-3.8
PromoterAI
0.11
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.24
gMVP
0.23
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2231004; hg19: chr6-29910762; API